RESPONSE BIOMEDICAL CORP Net Cash Provided by (Used in) Financing Activities, Continuing Operations
RESPONSE BIOMEDICAL CORP reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of -CAD 405.00 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2016-11-14
- RESPONSE BIOMEDICAL CORP net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-09-30 was -335.00K CAD.
- RESPONSE BIOMEDICAL CORP net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-06-30 was 269.00K CAD.
- RESPONSE BIOMEDICAL CORP net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-03-31 was -339.00K CAD.
- RESPONSE BIOMEDICAL CORP net cash provided by (used in) financing activities, continuing operations for the quarter ending 2015-12-31 was -355.00K CAD.
- RESPONSE BIOMEDICAL CORP net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was -1.09M CAD, a 137.00% decline from fiscal 2014.
- RESPONSE BIOMEDICAL CORP net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was 2.95M CAD, a 25.81% increase from fiscal 2013.
- RESPONSE BIOMEDICAL CORP net cash provided by (used in) financing activities, continuing operations for fiscal 2013 was 2.35M CAD.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2016-09-30 | -335.00K CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -66.00K CAD derived: sum of 2 quarters · filed 2016-11-14 | -405.00K CAD 10-Q · filed 2016-11-14 | -760.00K CAD derived: sum of 4 quarters · filed 2016-11-14 |
| 2016-06-30 | 269.00K CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -70.00K CAD 10-Q · filed 2016-08-15 | -425.00K CAD derived: sum of 3 quarters · filed 2016-08-15 | -744.00K CAD derived: sum of 4 quarters · filed 2016-11-14 |
| 2016-03-31 | -339.00K CAD 10-Q · filed 2016-05-16 | -694.00K CAD derived: sum of 2 quarters · filed 2016-05-16 | -1.01M CAD derived: sum of 3 quarters · filed 2016-11-14 | -1.32M CAD derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-12-31 | -355.00K CAD derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24 | -674.00K CAD derived: sum of 2 quarters · filed 2016-11-14 | -983.00K CAD derived: sum of 3 quarters · filed 2016-11-14 | -1.09M CAD 10-K · filed 2016-03-24 |
| 2015-09-30 | -319.00K CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -628.00K CAD derived: sum of 2 quarters · filed 2016-11-14 | -738.00K CAD 10-Q · filed 2016-11-14 | |
| 2015-06-30 | -309.00K CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -419.00K CAD 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | -110.00K CAD 10-Q · filed 2016-05-16 | |||
| 2014-12-31 | 2.95M CAD 10-K · filed 2016-03-24 | |||
| 2013-12-31 | 2.35M CAD 10-K · filed 2016-03-24 |